Effective COVID-19 Drug a 'Breakthrough' for Minority of Patients

Results from the large-scale Recovery Trial, affiliated with Oxford University in the UK, demonstrated that the inexpensive inflammatory drug dexamethasone can save thousands of lives of critically ill COVID-19 patients. Researchers and public health experts hail the findings as a breakthrough, and the low cost will be important to providing the treatment widely, even in poorer countries. There is no evidence that the drug benefits less seriously ill people, so medical professionals hope this may prevent a 'run' on the medication - which could reduce access for those who need it for other diseases, as happened with hydroxychloroquine. The caution, amid the excitement, is that a treatment that saves most patients - and a vaccine that can prevent COVID-19 infection, is still beyond the horizon. So keep doing the things you can to reduce your risks and those of others around you: wearing masks, observing physical distance where you can, and washing your hands regularly, as the World Health Organization urges.

UN Police hold a COVID-19 information session for vulnerable street children in Kananga, Democratic Republic of the Congo.


Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.